Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2343]
News [4865]
Articles [202]
Editorials [8]
Conferences [136]
elearning [14]
ECC 2013 Preview: Scientific programme highlights
Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013
Patient advocacy track 'personalised medicine'
Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan...
Patient advocacy track 'personalised medicine' ( Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
19 Jun 2013
ASCO 2013 highlights
Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
ASCO 2013 highlights ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013
New targets for squamos cell carcinoma
Dr Martin Reck – Hospital Grosshansdorf, Wohrendamm, Germany
New targets for squamos cell carcinoma ( Dr Martin Reck – Hospital Grosshansdorf, Wohrendamm, Germany )
16 May 2013
Integrating breast cancer genomics and proteomics
Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013
Next wave of successful drug therapy strategies in HER2-positive breast cancer
Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium
Next wave of successful drug therapy strategies in HER2-positive breast cancer ( Dr Hans Wildiers - University Hospital Leuven, Gasthuisberg, Belgium )
15 May 2013
Genetic and clinical factors best for predicting late recurrence in oestrogen...
Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013
How do we design trials that improve outcome?
Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013
Breast cancer heterogeneity no barrier to predictive testing
Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland
Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
15 May 2013
Measurement variation influences gene expression profiles of breast cancer
Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA
Measurement variation influences gene expression profiles of breast cancer ( Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2...
Dr Yanina Dockx - University of Antwerp, Edegem, Belgium
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab ( Dr Yanina Dockx - University of Antwerp, Edegem, Belgium )
15 May 2013
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast...
Prof Charles Perou - University of North Carolina School of Medicine, USA
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
14 May 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation